Price T Rowe Associates Inc Cin Cor Pharma, Inc. Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$10.75 - $29.84 $1.57 Million - $4.35 Million	145,745 Added 11.41%	1,423,124 $17.5 Million
Q3 2022 Nov 14, 2022	BUY	$19.9 - $38.94 $11.9 Million - $23.3 Million	597,757 Added 87.95%	1,277,379 $41.9 Million
Q2 2022 Aug 15, 2022	SELL	$13.67 - $25.74 $536,588 - $1.01 Million	-39,253 Reduced 5.46%	679,622 $12.8 Million
Q1 2022 May 16, 2022	BUY	$14.13 - $28.49 $10.2 Million - $20.5 Million	718,875 New	718,875 $12.6 Million

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.